BioRestorative Therapies, Inc.
BRTX
$0.19
-$0.01-3.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.57% | -14.38% | 50.25% | -226.37% | -49.91% |
| Total Depreciation and Amortization | 0.38% | -0.19% | 1.74% | 2.78% | 4.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.62% | -51.17% | -107.07% | 398.62% | 3.24% |
| Change in Net Operating Assets | 151.52% | 298.66% | 386.22% | -135.21% | -60.23% |
| Cash from Operations | 16.75% | -7.69% | 3.06% | -18.36% | -38.14% |
| Capital Expenditure | -- | -- | 100.00% | -193.55% | 78.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.16% | -6.31% | -11.28% | 55.56% | 55.25% |
| Cash from Investing | 20.18% | -6.31% | -9.92% | 54.44% | 63.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -344.51% | 1,400.00% | 83.33% | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -14.17% | 271.21% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.51% | -48.78% | -371.70% | 105.88% | -- |
| Cash from Financing | 1,972.62% | -105.55% | -18.72% | 965.16% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 195.37% | -391.82% | -52.05% | 172.31% | -23.44% |